Redeye: Scibase - Securing growth capital
Redeye updates the fair value range after the Q4 report and the share issue. The fair value range and Based case changes are temporary and could be altered depending on the outcome of the share issue. We do not, however, expect the value difference to be substantial after the outcome in March.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.